• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地中海地区痛风人群患帕金森病的风险:一项病例对照研究。

Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.

机构信息

EAP Encants, Institut Català de la Salut, Barcelona, Spain.

Unitat de Suport a la Recerca, Ambit Barcelona Ciutat, Barcelona, Spain.

出版信息

Joint Bone Spine. 2022 Nov;89(6):105402. doi: 10.1016/j.jbspin.2022.105402. Epub 2022 Apr 30.

DOI:10.1016/j.jbspin.2022.105402
PMID:35504516
Abstract

INTRODUCTION

High levels of serum urate has been associated to a neuroprotective effect in Parkinson's disease (PD) as an antioxidant agent. However, the relation between gout and PD remains contradictory.

OBJECTIVE

To study if the neuroprotective effect of serum urate is maintained in patients with gout in a large urban Mediterranean population.

METHODS

Primary care based matched case-control study, carried out using an electronic health record database from the public primary care health system of Barcelona. The database contains anonymous data from 1,520,934 patients. All patients, over 40 years old, with a new diagnostic record of PD, or a new prescription of dopaminergic drugs were included (incident cases). We randomly selected four controls for each case, matched by gender and age, with the frequency matching approach. Retrospective data of PD risk factors were also collected for each individual. A multivariate logistic regression model was used to evaluate the association of gout and PD, adjusted by the presence of other risk factors.

RESULTS

A new PD diagnosis was found in 17,629 individuals (incident diagnosis rate of 2.2 per 1000 individuals). Multivariate logistic regression model showed for gout: aOR=0.83 (0.76-0.91). When stratified by age, aOR for those under 75years was 0.99 (0.85-1.16) and 75 or over OR=0.77 (0.70-0.86). Dyslipidemia, hypertension and diabetes mellitus were associated with an increased risk of PD. Tobacco consumption was protective.

CONCLUSION

Our study, the first one made in a Mediterranean population, shows a PD protective effect of gout in both men and women over 75years old.

摘要

简介

高水平的血清尿酸与帕金森病(PD)的神经保护作用有关,作为一种抗氧化剂。然而,痛风与 PD 之间的关系仍然存在争议。

目的

在一个大型城市地中海人群中,研究痛风患者的血清尿酸的神经保护作用是否仍然存在。

方法

这是一项基于初级保健的匹配病例对照研究,使用巴塞罗那公共初级保健卫生系统的电子健康记录数据库进行。该数据库包含来自 1520934 名患者的匿名数据。所有年龄在 40 岁以上、有新的 PD 诊断记录或多巴胺能药物新处方的患者(首发病例)都被纳入研究。我们随机选择了每个病例的 4 名对照者,通过性别和年龄进行频数匹配。还为每个个体收集了 PD 危险因素的回顾性数据。使用多变量逻辑回归模型来评估痛风与 PD 的关联,同时调整其他危险因素的存在。

结果

在 17629 名个体中发现了新的 PD 诊断(发病率为每 1000 人 2.2 例)。多变量逻辑回归模型显示,痛风的比值比为 0.83(0.76-0.91)。按年龄分层,75 岁以下的比值比为 0.99(0.85-1.16),75 岁及以上的比值比为 0.77(0.70-0.86)。血脂异常、高血压和糖尿病与 PD 风险增加相关。吸烟则有保护作用。

结论

我们的研究,首次在一个地中海人群中进行,表明痛风对 75 岁以上的男性和女性的 PD 具有保护作用。

相似文献

1
Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.地中海地区痛风人群患帕金森病的风险:一项病例对照研究。
Joint Bone Spine. 2022 Nov;89(6):105402. doi: 10.1016/j.jbspin.2022.105402. Epub 2022 Apr 30.
2
Gout and the risk of Parkinson's disease: a cohort study.痛风与帕金森病风险:一项队列研究
Arthritis Rheum. 2008 Nov 15;59(11):1549-54. doi: 10.1002/art.24193.
3
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.痛风与多发性硬化症、帕金森病和运动神经元病之间的临床关联:记录链接研究。
BMC Neurol. 2015 Feb 28;15:16. doi: 10.1186/s12883-015-0273-9.
4
Clinical Association between Gout and Parkinson's Disease: A Nationwide Population-Based Cohort Study in Korea.韩国全国范围内基于人群的队列研究:痛风与帕金森病的临床关联。
Medicina (Kaunas). 2021 Nov 24;57(12):1292. doi: 10.3390/medicina57121292.
5
Urate and the risk of Parkinson's disease in men and women.尿酸与男性和女性帕金森病风险的关系。
Parkinsonism Relat Disord. 2018 Jul;52:76-82. doi: 10.1016/j.parkreldis.2018.03.026. Epub 2018 Mar 28.
6
Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data.老年人痛风与帕金森病风险:一项基于美国医疗保险数据的研究
BMC Neurol. 2019 Jan 5;19(1):4. doi: 10.1186/s12883-018-1234-x.
7
Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis.痛风与帕金森病发展之间的关联:系统评价和荟萃分析。
BMC Neurol. 2022 Oct 11;22(1):383. doi: 10.1186/s12883-022-02874-0.
8
Gout, hyperuricemia, and Parkinson's disease: a protective effect?痛风、高尿酸血症与帕金森病:保护作用?
Curr Rheumatol Rep. 2010 Apr;12(2):149-55. doi: 10.1007/s11926-010-0083-4.
9
Gout and risk of Parkinson disease: a prospective study.痛风与帕金森病风险:一项前瞻性研究。
Neurology. 2007 Oct 23;69(17):1696-700. doi: 10.1212/01.wnl.0000279518.10072.df.
10
Risk of Parkinson's disease following gout: a population-based retrospective cohort study in Taiwan.台湾地区痛风后帕金森病发病风险的基于人群的回顾性队列研究。
BMC Neurol. 2020 Sep 8;20(1):338. doi: 10.1186/s12883-020-01916-9.

引用本文的文献

1
Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence.合并症及其对帕金森病的影响:当前证据的叙述性概述
Int J Mol Sci. 2025 Mar 24;26(7):2942. doi: 10.3390/ijms26072942.
2
Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases.靶向尿酸:一种针对神经退行性疾病中氧化应激和神经炎症的有前景的干预措施。
Cell Commun Signal. 2025 Jan 3;23(1):4. doi: 10.1186/s12964-024-01965-4.
3
Renin-angiotensin system inhibitor use and risk of Parkinson's disease: a meta-analysis.
肾素-血管紧张素系统抑制剂的使用与帕金森病风险:一项荟萃分析。
Acta Neurol Belg. 2025 Feb;125(1):53-60. doi: 10.1007/s13760-024-02560-7. Epub 2024 Apr 26.
4
Inflammatory rheumatic diseases and the risk of Parkinson's disease: A systematic review and meta-analysis.炎症性风湿性疾病与帕金森病风险:一项系统评价与荟萃分析。
Front Neurol. 2022 Nov 10;13:999820. doi: 10.3389/fneur.2022.999820. eCollection 2022.
5
Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis.痛风与帕金森病发展之间的关联:系统评价和荟萃分析。
BMC Neurol. 2022 Oct 11;22(1):383. doi: 10.1186/s12883-022-02874-0.